HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study].

Abstract
Bullous pemphigoid is a bullous skin disease associated with basal membrane antibodies. At present, the first treatment of these lesions is with corticosteroids. In this randomized study we compared the clinical results obtained with methylprednisolone (MePr) in 28 patients and with prednisolone methylsulfobenzoate (MsPr) in 29 patients. Both drugs were administered orally in daily doses of 1 to 1.5 mg/kg bodyweight. Three clinical data were examined: the number of bullous lesions, the intensity of pruritus and the extent of erythema after 5 then 10 days of treatment. After 10 days, the number of bullous lesions had decreased by 83 p. 100 with MePr and by 78 p. 100 with MsPr, and the decrease of pruritus had been significantly more pronounced in the MePr group than in the Ms group (p < 0.05). There had been no difference between treatments in the regression of erythema. Altogether, good results were obtained in 22/28 patients under MsPr (78.6 p. 100) and 18/29 patients under MePr (62.1 p. 100). This raises the question of the value of pharmacokinetic studies not only with these two corticosteroids, but also with prednisone which seems to be better absorbed.
AuthorsB Dreno, B Sassolas, P Lacour, S Montpoint, I Lota, F Giordano, P Royer
JournalAnnales de dermatologie et de venereologie (Ann Dermatol Venereol) Vol. 120 Issue 8 Pg. 518-21 ( 1993) ISSN: 0151-9638 [Print] France
Vernacular TitleMéthylprednisolone versus méthylsulfobenzoate de prednisolone dans la pemphigoïde: étude comparative multicentrique.
PMID8304707 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Prednisolone
  • Methylprednisolone
Topics
  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Male
  • Methylprednisolone (therapeutic use)
  • Pemphigoid, Bullous (drug therapy)
  • Prednisolone (analogs & derivatives, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: